… Evidence to support the role of immune checkpoint inhibitors in EGFR-mutated lung cancers
… -driven lung tumors 8 ; however, in a retrospective analysis of 58 patients with advanced …

… radio-chemotherapy in patients with locally advanced non-small cell lung cancer (NSCLC),
it is not … Patients and methods This meta-analysis was based on individual patient data from …

… lung cancer has been a controversial topic, and findings have appeared inconsistent. In this
paper, we focus on lung cancer … , all 29 studies demonstrated lung cancer relative risk (RR) …

… Lung cancer is the most common cause of cancer death, claiming 1.59 million lives in 2012
… Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers and …

… lung cancer (MPLC), we conducted this study to address this issue by comparing the
prognosis of MPLC patients … the standard resection through a systemic review and meta-analysis. …

… We found that MPLC had better OS than the lung cancer patients with intrapulmonary
metastasis. And despite the tumor-free interval, the OS for metachronous MPLC was as good as …

… of this meta-analysis of human lung cancer … meta-analysis of human lung cancer miRNA
expression profiling studies might provide some clues of the potential biomarkers in lung cancer…

… The aim of this study was to evaluate the association between PLR and clinical outcome of
… for lung cancer are urgently needed. In this study, the authors conducted a meta-analysis to …

… with chemotherapy as first-line therapy in patients with advanced non–small-cell lung cancer
during the last 5 years. Hazard ratio meta-estimates for progression-free survival were for …

… present study the relationship between FEV 1 and lung cancer was modified by sex. Whether
women are more susceptible to lung cancer … for lung cancer in women compared with men. …